Katarína Chromá

Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress

Katarína Chromá, Martin Mistrík, Pavel Moudrý et al. · Oncogene · 2016 · 53 citations

Life Sciences, Molecular Biology, Oncology +16

Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway

Dušana Majera, Zdeněk Škrott, Katarína Chromá et al. · Cells · 2020 · 45 citations · Full text

Medicine, Oncology, Pharmacology +15

RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis

Pavel Moudrý, Katarína Chromá, Slađana Bursać et al. · Cell Death and Differentiation · 2021 · 33 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps

Zuzana Machacova, Katarína Chromá, Dávid Lukáč et al. · Nature Communications · 2024 · 23 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment

Katarína Chromá, Zdeněk Škrott, Ján Gurský et al. · Cell Death and Disease · 2022 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15